Gregor Holzer
Overview
Explore the profile of Gregor Holzer including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
140
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Calzavara-Pinton P, Chu C, Lapeere H, Rossi M, Ferrucci S, Chung W, et al.
Adv Ther
. 2024 Dec;
42(2):720-733.
PMID: 39621227
Introduction: Currently, limited data are available on long-term use of dupilumab to treat atopic dermatitis (AD) in a multinational real-world setting. The aim of this analysis was to report the...
2.
Calzavara-Pinton P, celakovska J, Lapeere H, Holzer G, Al-Ahmad M, Chu C, et al.
Adv Ther
. 2023 Oct;
40(12):5366-5382.
PMID: 37801232
Introduction: Insights into real-world treatment of atopic dermatitis (AD) are relevant to clinical decision making. The aim of this analysis was to characterize patients who receive dupilumab for AD in...
3.
Alkon N, Assen F, Arnoldner T, Bauer W, Medjimorec M, Shaw L, et al.
J Allergy Clin Immunol
. 2023 May;
152(2):420-435.
PMID: 37210042
Background: Chronic nodular prurigo (CNPG) is an inflammatory skin disease that is maintained by a chronic itch-scratch cycle likely rooted in neuroimmunological dysregulation. This condition may be associated with atopy...
4.
Sator P, Loewe R, Zamani O, Holzer G, Wolf P, Mlynek A, et al.
Wien Klin Wochenschr
. 2019 Oct;
131(19-20):485-492.
PMID: 31591676
Background: Fumaric acid esters are recommended in European guidelines for induction and maintenance treatment of patients with moderate to severe plaque psoriasis. A systemic medication with pure dimethyl fumarate without...
5.
Radakovic S, Holzer G, Tanew A
J Am Acad Dermatol
. 2013 Jan;
68(2):e61-3.
PMID: 23317997
No abstract available.
6.
Haider D, Holzer G, Schaller G, Weghuber D, Widhalm K, Wagner O, et al.
J Pediatr Gastroenterol Nutr
. 2006 Oct;
43(4):548-9.
PMID: 17033537
Objective: The insulin-mimetic adipocytokine visfatin has been linked to adiposity and the metabolic syndrome. Design: Cross-sectional study. Subjects: Eighty-three nondiabetic obese children and 40 healthy controls. Measurements: We analyzed plasma...
7.
Holzer G, Esterbauer H, Kronke G, Exner M, Kopp C, Leitinger N, et al.
Thromb Res
. 2006 Oct;
120(1):71-9.
PMID: 17014893
Introduction: Tissue factor (TF) plays a pivotal role in the generation of thrombin in atherothrombotic disease. The oxidized phospholipid 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphorylcholine (oxPAPC), an active compound of minimally oxidized low-density lipoprotein (MM-LDL),...
8.
Kapiotis S, Holzer G, Schaller G, Haumer M, Widhalm H, Weghuber D, et al.
Arterioscler Thromb Vasc Biol
. 2006 Sep;
26(11):2541-6.
PMID: 16973973
Background: Obesity is generally accepted as a risk factor for premature atherosclerosis. Subclinical inflammation as quantified by blood levels of C-reactive protein (CRP) contributes to the development and progression of...
9.
Exner M, Raith M, Holzer G, Gmeiner B, Wagner O, Kapiotis S
Forsch Komplementmed
. 2006 Apr;
13 Suppl 1:13-7.
PMID: 16582558
Background: The Tibetan herbal preparation Padma 28 has been shown to act as an anti-atherosclerotic agent in advanced peripheral arterial occlusive disease. We tested the effect of aqueous Padma 28...